NCT05112965 2026-01-07An Extension Study in Participants Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study (IMbrella C)Hoffmann-La RochePhase 3 Active not recruiting49 enrolled
NCT02322281 2019-08-14TIGER-3: Open Label, Multicenter Study of Rociletinib (CO-1686) Mono Therapy Versus Single-agent Cytotoxic Chemotherapy in Patients With Mutant EGFR NSCLC Who Have Failed at Least One Previous EGFR-Directed TKI and Platinum-doublet ChemotherapyClovis Oncology, Inc.Phase 3 Terminated149 enrolled 17 charts
NCT02900742 2019-04-12Clinical Study of Chinese Medicine Plus Chemotherapy Maintenance in Advanced Non Small Cell Lung CancerShanghai University of Traditional Chinese MedicinePhase 3 Completed71 enrolled
NCT00440414 2010-08-19Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC)Hellenic Oncology Research GroupPhase 3 Completed320 enrolled
NCT00035035 2006-07-19A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.Eli Lilly and CompanyPhase 3 Completed